
Pri-Med Podcasts
621 episodes — Page 7 of 13
Bad News for E-Cigarette Users—Possible Link Between E-Cigarettes And ED - Frankly Speaking Ep 267
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-267 Overview: The clinical literature is filled with new and evolving evidence on the use of e-cigarettes and potential harms. The question of their use as a harm reduction strategy is a hotly debated topic—pitting traditional combustible tobacco with its well-known effect on morbidity and mortality against electronic nicotine delivery systems (ENDS), which although not harmless, are considered less harmful than smoked cigarettes. Recent evidence is emerging on the potential cardiovascular risks posed by newer generations of ENDS with far greater delivery of nicotine. Join us while we discuss the findings from a recent study that examines ENDS use and associated increase rates of erectile dysfunction (ED) and how this information may impact your practice. Episode resource links: El-Shahawy O, Shah T, Obisesan OH, Durr M, Stokes AC, Uddin I, Pinjani R, Benjamin EJ, Mirbolouk M, Osei AD, Loney T, Sherman SE, Blaha MJ. Association of E-Cigarettes With Erectile Dysfunction: The Population Assessment of Tobacco and Health Study. Am J Prev Med. 2022 Jan;62(1):26-38. doi: 10.1016/j.amepre.2021.08.004. Epub 2021 Nov 30. PMID: 34922653. Caponnetto P. Well-being and harm reduction, the consolidated reality of electronic cigarettes ten years later from this emerging phenomenon: A narrative review. Health Psychol Res. Dec 30 2020;8(3):9463. doi:10.4081/hpr.2020.9463 Hartmann-Boyce J, McRobbie H, Lindson N, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. Apr 29 2021;4:CD010216. doi:10.1002/14651858.CD010216.pub5 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Fever Free: Acetaminophen or Ibuprofen?- Frankly Speaking Ep 266
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-266 Overview: ‘Tis the season for pediatric fevers! Join us to review a recent meta-analysis looking at 18 studies with patients younger than 2 years old who received acetaminophen or ibuprofen for fever or pain to determine if one medication should be recommended first, before the other. After this session, you’ll be able to confidently advise parents of young children on how best to manage fever and/or pain at home with over-the-counter medications. Episode resource links: Long B, Gottlieb M. Ibuprofen vs. Acetaminophen for Fever or Pain in Children Younger Than Two Years. Am Fam Physician. 2022 Jan ;105(1):19. Wong T, Stang AS, Ganshorn H, Hartling L, Maconochie IK, Thomsen AM, Johnson DW. Combined and alternating paracetamol and ibuprofen therapy for febrile children. Evid Based Child Health. 2014 Sep;9(3):675-729. doi: 10.1002/ebch.1978. PMID: 25236309. Sullivan JE, Farrar HC. Fever and Antipyretic Use in Children. Pediatrics (2011) 127 (3): 580-587. (Reaffirmed 2016) Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato
Fluvoxamine as a Treatment for COVID-19 - Frankly Speaking Ep 265
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-265 Overview: Most cases of COVID-19 will resolve without interventions, but some patients are at high risk for complications. Several treatment options for high-risk patients are now available to help prevent the need for hospitalization. Join us to review a recent large, randomized trial evaluating fluvoxamine as a treatment for high-risk patients who were diagnosed with COVID-19. Episode resource links: Reis G, et al. TOGETHER investigators. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob Health. 2022 Jan;10(1):e42-e51 Berwanger O. Fluvoxamine for outpatients with COVID-19: where do we stand? Lancet Glob Health. 2022 Jan;10(1):e2-e3. doi: 10.1016/S2214-109X(21)00501-5 https://activ6study.org/ Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Richard Onorato
COVID-19 and Children - Frankly Speaking Ep 264
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-264 Overview: Get answers to your questions on COVID-19 infection in children. Listen to this podcast to review outcomes and potential risk factors associated with acute COVID-19 infection in this population. Finally, learn the status of immunizations for children younger than 5 years of age. Episode resource links: JAMA Netw Open. 2022;5(1):e2142322. doi:10.1001/jamanetworkopen.2021.42322 Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato

COVID-19 and Children - Frankly Speaking Ep 264
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-264 Overview: Get answers to your questions on COVID-19 infection in children. Listen to this podcast to review outcomes and potential risk factors associated with acute COVID-19 infection in this population. Finally, learn the status of immunizations for children younger than 5 years of age. Episode resource links: JAMA Netw Open. 2022;5(1):e2142322. doi:10.1001/jamanetworkopen.2021.42322 Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato

Oral Anti−COVID-19 Medications—a Game Changer? - Frankly Speaking Ep 263
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-263 Overview: The FDA’s recent emergency use authorization (EUA) for oral agents to treat COVID-19 means that primary care providers (PCPs) will be on the frontline of treating patients with COVID-19. Therefore, PCPs must understand who is eligible for such treatments and how to prescribe them. We will discuss the results of the recent FDA EUA for Pfizer’s Paxlovid and Merck’s molnupiravir antiviral agents and give you the information you need to confidently prescribe them. Episode resource links: FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR MOLNUPIRAVIR (fda.gov) FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVID (fda.gov) Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato

Menopausal Transition: Bothersome Symptoms Sooner Than You Expect! - Frankly Speaking Ep 262
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-262 Overview: Join us as we discuss menopausal transition and the unique qualities and symptoms that are bothersome to women at an early age. Episode resource links: Coslov, N., Richardson, M. K., & Woods, N. F. (2021). Symptom experience during the late reproductive stage and the menopausal transition: observations from the Women Living Better survey. Menopause (New York, N.Y.), 28(9), 1012–1025. https://doi.org/10.1097/GME.0000000000001805 https://pubmed.ncbi.nlm.nih.gov/34313615/ ACOG Practice Guidelines: Clinical Guidelines on the Management of Menopausal Symptoms: https://www.aafp.org/afp/2014/0901/p338.html Women Living Better Website: https://womenlivingbetter.org/ Maki, P. M., Kornstein, S. G., Joffe, H., Bromberger, J. T., Freeman, E. W., Athappilly, G., Bobo, W. V., Rubin, L. H., Koleva, H. K., Cohen, L. S., Soares, C. N., & Board of Trustees for The North American Menopause Society (NAMS) and the Women and Mood Disorders Task Force of the National Network of Depression Centers (2018). Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations. Menopause (New York, N.Y.), 25(10), 1069–1085. https://doi.org/10.1097/GME.0000000000001174 https://pubmed.ncbi.nlm.nih.gov/30179986/ Johnson, A., Roberts, L., & Elkins, G. (2019). Complementary and Alternative Medicine for Menopause. Journal of evidence-based integrative medicine, 24, 2515690X19829380. https://doi.org/10.1177/2515690X19829380 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419242/ Barnard, N; Kahleova, H; Holtz, D; del Aguila, F; Neola, M; Crosby, Lelia M.& Holubkov, R (2021). The Women's Study for the Alleviation of Vasomotor Symptoms (WAVS): a randomized, controlled trial of a plant-based diet and whole soybeans for postmenopausal women, Menopause 28 (10), 1150-1156 doi: 10.1097/GME.0000000000001812 Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato

Getting in the LOOP About Atrial Fibrillation and Stroke - Frankly Speaking Ep 261
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-261 Overview: Stroke is a major health problem, and the risk of stroke is five-times higher in individuals with atrial fibrillation (AF) than those without. AF can be asymptomatic or subclinical. In 18% of AF patients, the condition is only detected at the time of stroke. It is not known whether individuals whose AF is deterred via screening carry a similar risk to individuals with known AF. A recent randomized trial evaluated a screening program for AF in individuals at high risk of stroke; for individuals identified with AF, anticoagulation was given for stroke prevention. Episode resource links: Svendsen JH, Diederichsen SZ, Højberg S et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial. Lancet. 2021 Oct 23;398(10310):1507-1516. Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato

Avoiding Aspirin in the Elderly: More Than Increased Bleeding Risk - Frankly Speaking Ep 260
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-260 Overview: We will review the current USPSTF recommendations regarding aspirin use to reduce the risk of CVD and colorectal cancer. Additionally, we will discuss as well as the findings of the ASPREE (ASPirin in reducing events in the elderly) randomized clinical trial. Episode resource links: POEMs: In Older Adults, Aspirin Increases the Risk of Metastatic of Stage 4 Cancers and Cancer Mortality. Barry, Henry C. Am Fam Physician. 2021 Sep; 104(2):online Effect of Aspirin on Cancer Incidence and Mortality in Older Adults. McNeil, John. JNCI: Journal of the National Cancer Institute Volume: 113 Issue 3 (2021) ISSN: 0027-8874 Online ISSN: 1460-2105 Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato

Improving Recovery from Concussion: New Evidence That May Help Post-Concussion Recuperation - Frankly Speaking EP 259
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-259 Overview: Per CDC data, approximately 2.5 million Americans present each year to emergency departments with head injuries, and 15% of all high school students report experiencing at least one concussion. Current guidelines recommend physical and cognitive rest for 24-48 hours post-concussion with minimal guidance on screen time parameters. Recent evidence is emerging that supports avoidance of screen time and encouragement of aerobic activity as strategies to shorten and lessen post-concussion symptoms. Join us as we discuss 2 recent studies regarding screen-time and aerobic exercise that add critical information to best practice for reducing post-concussion symptoms. Episode resource links: John J Leddy, Christina L Master, Rebekah Mannix, Douglas J Wiebe, Matthew F Grady, William P Meehan, Eileen P Storey, Brian T Vernau, Naomi J Brown, Danielle Hunt, Fairuz Mohammed, Andrea Mallon, Kate Rownd, Kristy B Arbogast, Adam Cunningham, Mohammad N Haider, Andrew R Mayer, Barry S Willer. Early targeted heart rate aerobic exercise versus placebo stretching for sport-related concussion in adolescents: a randomised controlled trial. The Lancet Child & Adolescent Health, 2021; DOI: 10.1016/S2352-4642(21)00267-4 Macnow T, Curran T, Tolliday C, et al. Effect of Screen Time on Recovery From Concussion: A Randomized Clinical Trial. JAMA Pediatr. Published online September 07, 2021. doi:10.1001/jamapediatrics.2021.2782 https://jamanetwork.com/journals/jamapediatrics/article-abstract/2783638#graphical-abstract-tab DePadilla L, Miller GF, Jones SE, Peterson AB, Breiding MJ. Self-reported concussions from playing a sport or being physically active among high school students—United States, 2017. MMWR Morb Mortal Wkly Rep. 2018;67(24):682-685. doi:10.15585/mmwr.mm6724a3 University at Buffalo. (2021, September 30). Aerobic exercise after a sport-related concussion speeds recovery in adolescent athletes, study suggests: Daily aerobic exercise significantly reduced the risk of prolonged recovery. ScienceDaily. Retrieved October 2, 2021 from www.sciencedaily.com/releases/2021/09/210930213654.htm McCrory P ,Meeuwisse W,Dvorak J,etal. Consensus statement on concussion in sport—the 5th International Conference on Concussion in Sport held in Berlin, October 2016. Br J Sports Med. 2017;51(11):838-847. doi:10.1136/bjsports-2017- 097699 Centers for Disease Control and Prevention. Recovery from concussion. Centers for Disease Control and Prevention; 2019. Accessed October 12, 2020. https://www.cdc.gov/headsup/basics/ concussion_recovery.html. Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato

S1 Ep 1A Brainy Approach to Treating Chronic Low Back Pain - Frankly Speaking Ep 258
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-258 Overview: Chronic pain affects 20% of people in the United States, and chronic low back pain is the most common cause of chronic pain. Although some treatments can reduce the severity of the pain, the persistence of chronic low back pain is a source of frustration for both patients and clinicians. Join us to discuss how behavioral and psychological therapy should be part of the treatment for chronic low back pain and how new approaches may be much more effective than existing therapies. Episode resource links: Ashar YK, Gordon A, Schubiner H, et al. Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial. JAMA Psychiatry. Published online September 29, 2021. Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato

Recommendations for the Treatment of Gout - Frankly Speaking Ep 257
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-257 Overview: Gout is a common condition seen in primary care, and the incidence and prevalence continue to rise. Despite previous recommendations from the American College of Rheumatology, urate-lowering therapy is still underused. Listen to this episode for a concise overview of the American College of Rheumatology’s updates for the management of gout and walk away with a clear understanding of the first-line treatment options for acute gout flares. Episode resource links: Management of Gout: Update from the American College of Rheumatology. Dakkak, M., Lanney, H. Am Fam Physician. 2021 Aug ;104(2):209-210. 2020 American College of Rheumatology Guideline for the Management of Gout. Fitzgerald, J. D. et al. Arthritis Care Res (Hoboken). June 2020;72(6):744–760 [published corrections appear in Arthritis Care Res (Hoboken). 2020;72(8):1187, and Arthritis Care Res (Hoboken). 2021;73(3):458] Guest: Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato

Favorite Podcast of 2021 - Frankly Speaking EP 256
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-256 Overview: Live at Pri-Med East! In this episode, each podcaster will discuss the most impactful paper and podcast of the year. Episode resource links: Ngan, H.Y, et al (2021), Diabet Med, 38: e14525. https://doi.org/10.1111/dme.14525 J Clin Gastroenterol 2021: DOI: 10.1097/MCG.0000000000001561 Mehta RS, etal. JAMA Intern Med. doi:10.1001/jamainternmed.2020.7238 https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication Hypertension. 2021;78:591–603. DOI: 10.1161/HYPERTENSIONAHA.120.16667 Guest: Susan Feeney, DNP, FNP-BC, NP-C, Alan M. Ehrlich, MD, FAAFP, Jill M. Terrien, PhD, ANP-BC, Jillian Joseph, MSPAS, PA-C Music Credit: Richard Onorato

Peaceful, Easy Feeling: Can Mindfulness Exercise Improve Asthma-Related Quality of Life? - Frankly Speaking Ep 255
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-255 Overview: Asthma is one of the most prevalent conditions, affecting almost 340 million individuals across the globe and approximately 25 million Americans, or 7.8% of the US population. Treatment is complex and goals of therapy are elusive for many. Anxiety and other concerns are common in those diagnosed with asthma and can worsen outcomes. A recent study from the UK found the use of a mindfulness app was associated with improved asthma-related quality-of-life indicators. Join us while we discuss this study’s implications for helping patients with asthma in primary care. Episode resource links: Ainsworth, B., Stanescu, S., Stuart, B., Russell, D., Liddiard, M., Djukanovic, R., & Thomas, M. (2021). A feasibility trial of a digital mindfulness-based intervention to improve asthma-related quality of life for primary care patients with asthma. Journal of Behavioral Medicine. Advance online publication. https://doi.org/10.1007/s10865-021-00249-3 CDC Most Recent National Asthma Data: https://www.cdc.gov/asthma/most_recent_national_asthma_data.htm Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato

Older Adults and Loneliness—Avoid High-Risk Medications - Frankly Speaking Ep 254
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-254-2 Overview: Older adults who suffer from loneliness may be at risk of overusing medications prescribed for pain, insomnia, depression, or anxiety. Replacing these medications with social interventions may improve outcomes and help patients avoid adverse consequences. Join us as we discuss the importance of reviewing medications and assessing for loneliness in older adults to prevent adverse events and outcomes. Episode resource links: Kotwal, A. A., Steinman, M. A., Cenzer, I., & Smith, A. K. (2021). Use of High-risk Medications Among Lonely Older Adults: Results From a Nationally Representative Sample. JAMA internal medicine, e213775. Advance online publication. https://doi.org/10.1001/jamainternmed.2021.3775 https://pubmed.ncbi.nlm.nih.gov/34309620/ Education for Patients: Tips on Staying Connected—National Institutes on Aging https://www.nia.nih.gov/health/loneliness-and-social-isolation-tips-staying-connected Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato

The End of ACE Inhibitors? - Frankly Speaking Ep 253
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-253 Overview: ACE (angiotensin-converting enzyme) inhibitors and ARBs (angiotensin receptor blockers) are both recommended as first-line treatments for hypertension. ACE inhibitors have known side effects, such as cough, that are frustrating for many patients, while ARBs appear to have less annoying side effects. This podcast will review a recently published retrospective, comparative cohort study comparing the effectiveness and safety of ACE inhibitors vs ARBs in the first-line treatment of hypertension. Episode resource links: Hypertension. 2021;78:591–603. DOI: 10.1161/HYPERTENSIONAHA.120.16667 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127–e248. doi: 10.1016/j.jacc.2017.11.006 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato

Contraception: When Do We Start Them? - Frankly Speaking Ep 252
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-252 Overview: For patients who would like to prevent pregnancy, many options—both hormonal and nonhormonal—exist. Despite the availability of multiple options, many patients do not use them because of either a lack of knowledge or a lack of access, the latter being especially true in uninsured and non−English-speaking communities. Research has shown over the years that while unintended pregnancies have decreased in the United States, more can be done, and primary care providers can play an important role in helping to further decrease and eliminate barriers to contraception. Episode resource links: Lesnewski, R. (2021). Initiating Hormonal Contraception. American Family Physician, 103(5), 291-300. Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato

Primary HPV Testing Alone for Cervical Cancer Screening: a Review of Recent Guideline Updates - Frankly Speaking Ep 251
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-251 Overview: Primary care providers should be up to date on the changes to the guidelines for cervical cancer screening to be able to guide patients in shared decision-making about health maintenance. Join us to review the recent changes to cervical cancer screening guidelines as recommended by the American Cancer Society. Episode resource links: Cervical Cancer Screening: Updated Guidelines from the American Cancer Society. Am Fam Physician. 2021 Sep; 104(2):314-315. American College of Obstetricians and Gynecologists. Updated cervical cancer screening guidelines. Practice advisory. April 2021. Accessed September 30, 2021. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines Fontham, ETH, Wolf, AMD, Church, TR, et al. Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update from the American Cancer Society. CA Cancer J Clin. 2020. https://doi.org/10.3322/caac.21628. Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato

Time to Recommend the Use of Salt Substitutes for CVD Prevention? - Frankly Speaking Ep 250
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-250 Overview: While the data conflict on how much sodium intake is optimal for preventing cardiovascular disease, it is clear that daily salt intake for most Americans exceeds what is recommended. However, restricting salt intake on an individual or on a public health level has been controversial. An interesting alternative is the use of salt substitutes, which can help to decrease sodium intake while increasing potassium intake, and both have been associated with lowering blood pressure. Join us to hear a discussion on the results of the recently published studies on salt and cardiovascular disease, along with an overview of the Salt Substitute and Stroke Study (SSaSS). Episode resource links: Neal B, Wu Y, Feng X, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med. DOI: 10.1056/NEJMoa2105675 O’Donnell M, Mente A, Alderman MH, et al. Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake, European Heart Journal, Volume 41, Issue 35, 14 September 2020, Pages 3363–3373, https://doi.org/10.1093/eurheartj/ehaa586 Circulation. 2021;143:1542–1567. DOI: 10.1161/CIRCULATIONAHA.120.050371 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato

Using DOACs for Valvular Atrial Fibrillation - Frankly Speaking Ep 249
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-249 Overview: For non-valvular atrial fibrillation, physicians, patients, and guideline organizations all prefer direct oral anticoagulants (DOACs) over vitamin K antagonists, such as warfarin, for thromboembolic prophylaxis. For those with valvular atrial fibrillation, the data for safety and efficacy have been limited because randomized trials comparing DOACs to warfarin often exclude patients with valvular atrial fibrillation. Join us to explore new data that shed light on the use of DOACs in valvular atrial fibrillation. Episode resource links: Dawwas GK, Dietrich E, Cuker A, Barnes GD, Leonard CE, Lewis JD. Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study. Ann Intern Med. 2021;174(7):910-919. Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato

Aspirin—Not Really for Primary Prevention - Frankly Speaking Ep 248
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-248 Overview: Join us to hear a discussion on the important changes the AHA/ACC and USPSTF have made to their positions on the use of aspirin for primary prevention of cardiovascular disease. The organizations note that while aspirin for primary prevention lowers the risk of a myocardial infarction, its harmful effects may outweigh its benefits. Learn the aspirin recommendations for your patients in their 40s, 50s, and 60s who are at higher risk for a cardiovascular event. Episode resource links: New: https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication Old: https://www.aafp.org/afp/2016/1015/od1.html https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato

Early Action in HCC: The Role of Primary Care in Hepatocellular Carcinoma Management
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/early-action-in-hcc-episode-three Overview: This podcast is the third in a three-part series addressing the urgency for early identification and improved care for patients with hepatocellular carcinoma (HCC). In this episode, two experts discuss exciting changes in the HCC treatment landscape, and how primary care providers can help with follow-up and care coordination. Guest: Ghassan Abou-Alfa, MD, MBA & Amit G. Singal, MD, MS

Expanding Access to IUDs:
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/expanding-access-to-IUDs Overview: In this concise and informative podcast, listen to family planning expert Katharine White, MD, review the current landscape of intrauterine device (IUD) options available to your patients. She will describe the current approved IUD options and a case example to help you understand how to counsel patients about IUDs. After listening, you will be equipped to identify patients who would benefit from IUDs and help these patients pick the best one for them. If you are interested in getting further hands-on training related to IUD insertion, management, and removal, check out the list of resources provided with this activity that can enable you to incorporate this important skill into your practice. Guest: Katharine O’Connell White, MD, MPH

A Fishy Method to Prevent Migraines - Frankly Speaking Ep 247
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-247 Overview: When it comes to chronic migraines, your first-line prevention is probably medication, but according to a new study, it may not have to be. Certain foods may play a role in increasing and decreasing migraine recurrence. Join us to review a recent randomized controlled trial aimed at preventing migraines in those with chronic migraines. Episode resource links: BMJ 2021; 374 :n1448 doi:10.1136/bmj.n1448; doi: https://doi.org/10.1136/bmj.n1448 The association of dietary patterns with migraine attack frequency in migrainous women. Nutritional Neuroscience 23:9, pages 724-730 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato

Early Action in HCC: Learning From Past Experience
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/early-action-in-hcc-episode-two Overview: This podcast is the second in a three-part series addressing the urgency for early identification and improved care for patients with hepatocellular carcinoma (HCC). In this episode, two experts discuss three HCC patient cases and examine the role of screening and referral in their disease course trajectory. Guest: Ghassan Abou-Alfa, MD, MBA & Amit G. Singal, MD, MS

Muscle Relaxants for Low Back Pain: Are They Worth the Risk? - Frankly Speaking Ep 246
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-246 Overview: Low back pain often leads to disability and loss of income and is a significant burden on patients and the healthcare system. While muscle relaxants are the third most common prescribed drugs in the treatment of low back pain, recent data demonstrating its use and efficacy are limited. This session discusses a recent systematic review of the safety, efficacy, and accepted use of muscle relaxants in the treatment of low back pain. Don’t miss this opportunity to learn how to provide low back pain treatments that have clear benefits for your patients. Episode resource links: Cashin A G, Folly T, Bagg M K, Wewege M A, Jones M D, Ferraro M C et al. Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis BMJ 2021; 374 :n1446 doi:10.1136/bmj.n1446 https://pubmed.ncbi.nlm.nih.gov/34233900/ Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato

Populations at High-Risk for Influenza: Children
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: Overview: In this short podcast, you will hear guideline-based answers to important questions about managing influenza in the pediatric population. Find out which children are considered high risk for complications and what those risks mean for vaccine selection. Hear expert tips on how to discuss the sensitive issue of influenza vaccination with vaccine-hesitant parents. Know how to accurately diagnose influenza in children in the midst of the COVID-19 pandemic. And lastly, learn which influenza treatments are approved for children and the role antivirals play in influenza prophylaxis in this population. Hosts: Robert H. Hopkins Jr., MD, FACP, FAAP; Charles Vega, MD, FAAFP Executive Producer: Margaret Oliverio, MD

Populations at High-Risk for Influenza: Cardiometabolic Disease
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/influenza-populations-at-high-risk-3 Overview: Join us to discover why it is important to prevent influenza and treat patients with influenza who have cardiometabolic disease. After this brief podcast, you will be able to identify the types of cardiovascular and metabolic diseases that put patients at high risk of influenza complications and determine which patients should get the high-dose influenza vaccine, according to recent data. You will also be able to answer the question of whether anti-influenza drugs affect the risk of incident cardiovascular events. Find out all this and more to protect your patients with cardiometabolic disease this influenza season. Hosts: Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC; Charles Vega, MD, FAAFP Executive Producer: Margaret Oliverio, MD

Populations at High-Risk for Influenza: Older Adults
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/influenza-populations-at-high-risk-2 Overview: This expert-led podcast arms you with what you need to know to effectively manage influenza in older adults, a population at increased risk for complications. Get the latest guidance on everything from choosing the appropriate vaccine for this age group to preventing the spread of influenza in long-term care facilities. Hear the most up-to-date recommendations for how to diagnose and treat older adults with influenza and find out if there are any risks associated with antivirals for this patient population. If you provide care to older adults this influenza season, you can’t miss this session. Hosts: Mary W. Montgomery, MD; Charles Vega, MD, FAAFP Executive Producer: Margaret Oliverio, MD

Populations at High-Risk for Influenza: CDC and IDSA Recommendations
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/influenza-populations-at-high-risk-1 Overview: This brief podcast will answer your most salient questions about managing influenza in high-risk patients, starting with how to identify those patients and determine their risk for developing complications. Next, you will listen to the experts discuss the latest CDC and IDSA recommendations for preventing influenza—including the use of post-exposure prophylaxis—in this vulnerable patient population. Finally, you will hear the recommendations for testing for influenza—within the context of the COVID-19 pandemic—and treating patients with influenza at high risk for complications Hosts: Mary W. Montgomery, MD; Charles Vega, MD, FAAFP Executive Producer: Margaret Oliverio, MD

MRI for Elevated PSA - Frankly Speaking Ep 245
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-245 Overview: When your patient has an elevated screening PSA level, your first inclination may be to refer for a biopsy, but have you considered obtaining a pre-biopsy MRI? In this podcast, we will review the appropriate management for an elevated screening PSA. You’ll want to hear about the new benefit of obtaining a pre-biopsy MRI to guide diagnostic procedures. Episode resource links: NEJM July 9, 2021; DOI: 10.1056/NEJMoa2100852\ Urology 2016 Apr;90:32-7. doi: 10.1016/j.urology.2015.11.046 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato

Early Action in HCC Episode 1: The Changing Epidemiology of Liver Cancer
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/early-action-in-hcc-episode-one Overview: This podcast is the first in a three-part series addressing the urgency for early identification and improved care for hepatocellular carcinoma (HCC). In this episode, two experts discuss the prevalence and mortality rates associated with liver cancer and highlight disparities impacting this patient population. Guideline recommendations to improve screening/referral will also be covered. Guest: Ghassan Abou-Alfa, MD, MBA

Can Artificial Intelligence Predict and Prevent Suicide? - Frankly Speaking Ep 244
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-244 Overview: Suicide and attempted suicide are significant health issues affecting the United States and the world. Are you aware of the tools available to you that can support suicide prevention strategies and save lives? Don’t miss this session to learn about how the use of an electronic health record in a large health system may help predict suicide attempts. Episode resource links: Walsh CG, Johnson KB, Ripperger M, Sperry S, Harris J, Clark N, Fielstein E, Novak L, Robinson K, Stead WW. Prospective Validation of an Electronic Health Record-Based, Real-Time Suicide Risk Model. JAMA Netw Open. 2021 Mar 1;4(3):e211428. doi: 10.1001/jamanetworkopen.2021.1428. PMID: 33710291; PMCID: PMC7955273 doi: 10.1001/jamanetworkopen.2021.1428 Liang, Angela, and Paul Nestadt S . "Suicide Risk in the COVID-19 Pandemic." Johns Hopkins Psychiatry Guide, 2021. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Psychiatry_Guide/787393/all/Suicide_Risk_in_the_COVID_19_Pandemic. Guest: Jill M. Terrien PhD, ANP-BC Music Credit: Richard Onorato

“Can You Hear Me Now?”— Aging, Hearing Impairment, and Physical Function - Frankly Speaking Ep 243
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-243 Overview: Evidence strongly supports a correlation between hearing impairment in older adults and decline in physical functioning. A recent population cohort study of older adults revealed that hearing impairment was associated with poorer physical function, reduced walking endurance, and accelerated decline. Join us while we discuss this evidence and how to apply it to your practice. You’ll walk away with strategies to promote hearing assessment and to help optimize physical functioning in your older adult patients. Episode resource links: Brenowitz WD, Wallhagen MI. Does Hearing Impairment Affect Physical Function?: Current Evidence, Potential Mechanisms, and Future Research Directions for Healthy Aging. JAMA Netw Open. 2021 Jun 1;4(6):e2114782. doi: 10.1001/jamanetworkopen.2021.14782. PMID: 34170308. Martinez-Amezcua P, Powell D, Kuo PL, Reed NS, Sullivan KJ, Palta P, Szklo M, Sharrett R, Schrack JA, Lin FR, Deal JA. Association of Age-Related Hearing Impairment With Physical Functioning Among Community-Dwelling Older Adults in the US. JAMA Netw Open. 2021 Jun 1;4(6):e2113742. doi: 10.1001/jamanetworkopen.2021.13742. PMID: 34170305; PMCID: PMC8233700. Martinez-Amezcua P, Kuo PL, Reed NS, Simonsick EM, Agrawal Y, Lin FR, Deal JA, Ferrucci L, Schrack JA. Association of hearing impairment with higher level physical functioning and walking endurance: Results from the Baltimore Longitudinal Study of Aging (BLSA). J Gerontol A Biol Sci Med Sci. 2021 May 18:glab144. doi: 10.1093/gerona/glab144. Epub ahead of print. PMID: 34003883. Croll, P.H., Vinke, E.J., Armstrong, N.M. et al. Hearing loss and cognitive decline in the general population: a prospective cohort study. J Neurol 268, 860–871 (2021). https://doi.org/10.1007/s00415-020-10208-8 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato

Cutting Through the Fog: Recognizing Gluten-Induced Neurocognitive Impairment - Frankly Speaking Ep 242
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-242 Overview: Gluten exposure is known to cause a number of problems in both those with celiac disease and those with non-celiac gluten sensitivity. One aspect that has not received much attention from the research community is the neurocognitive impairment that can occur following gluten exposure in these individuals. Join us for this podcast to dive into a recent article that describes these effects. Episode resource links: Edwards George JB, Aideyan B, Yates K, et al. Gluten-induced Neurocognitive Impairment: Results of a Nationwide Study [published online ahead of print, 2021 May 28]. J Clin Gastroenterol. 2021 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato
“Could It Be My Thyroid?” The Quandary of Subclinical Hypothyroidism - Frankly Speaking Ep 241
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-241 Overview: Seven percent of the US population has an active levothyroxine prescription, which is significantly greater than the number of people diagnosed with overt hypothyroidism. Many of these prescriptions appear to be for the treatment of subclinical hypothyroidism and other conditions in euthyroid individuals. Join us to uncover the latest findings on the use of levothyroxine and what the evidence tells us about appropriate use and misuse of this drug. Episode resource links: Brito, J., Ross, J., El Kawkgi, O., Maraka, S., Deng, Y., Shah, N., Lipska, K. & (9000). Levothyroxine Use in the United States, 2008-2018. JAMA Internal Medicine, Publish Ahead of Print, doi: 10.1001/jamainternmed.2021.2686. Johansen, M., Marcinek, J., Yun, J. & (2020). Thyroid Hormone Use in the United States, 1997–2016. Journal of the American Board of Family Medicine, 33 (2), 284-288. doi: 10.3122/jabfm.2020.02.190159. Jeffrey R. Garber, Rhoda H. Cobin,Hossein Gharib,James V. Hennessey, Irwin Klein, Jeffrey I. Mechanick, Rachel Pessah-Pollack, Peter A. Singer,Kenneth A. Woeber. Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association; November–December 2012. https://www.endocrinepractice.org/article/S1530-891X(20)43030-7/fulltext; https://www.endocrinepractice.org/action/showPdf?pii=S1530-891X%2820%2943030-7 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato

Continuous Glucose Monitoring (CGM) for Type 2 Diabetes Mellitus (T2DM) - Frankly Speaking Ep 240
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-240 Overview: Have you considered continuous glucose monitoring (CGM) for your patients with suboptimally controlled type 2 diabetes mellitus (T2DM) on at least 3 injections of insulin per day? This session will give you the information you need to confidently initiate CGM in appropriate patients. You’ll walk away with a clear understanding of the different CGM options and the benefits and challenges of CGM. Episode resource links: Ida S, Kaneko R, Murata K. Utility of Real-Time and Retrospective Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials. J Diabetes Res. 2019 Jan 15;2019:4684815. doi: 10.1155/2019/4684815. PMID: 30775385; PMCID: PMC6350576. Maiorino et al. Diabetes Care. 2020;43:1146–1156 Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato

Update From the CDC: New Gonorrhea Guidelines - Frankly Speaking Ep 239
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-239 Overview: Join us to discuss the CDC’s new guidelines for the management of sexually transmitted infections due to Neisseria gonorrhoeae. You’ll walk away with recommendations for how to address urogenital, rectal, and pharyngeal infections. You’ll also discover alternative regimens for patients allergic to first-line therapy and understand how to manage coinfection with chlamydia. Episode resource links: St. Cyr S, Barbee L, Workowski KA, et al. Update to CDC’s Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep 2020;69:1911–191 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato

Lung Cancer Screening—Expanded Recommendations! - Frankly Speaking Ep 238
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-238 Overview: Join us to discuss important changes in the 2021 USPSTF recommendation on lung cancer screening. Given lung cancer’s high prevalence and poor prognosis in later stages, it is important for primary care clinicians to know which patients to screen and what method to use. You’ll also learn the appropriate time to stop screening. Episode resource links: Screening for Lung Cancer US Preventive Services Task Force Recommendation Statement JAMA. 2021;325(10):962-970. doi:10.1001/jama.2021.1117 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato

Identifying Risk in Women to Prevent CVD - Frankly Speaking Ep 237
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-237 Overview: Solid evidence shows that adverse pregnancy outcomes (APOs) correlate with an increased risk of cardiovascular disease (CVD) in women. Evidence is also becoming clearer that lactation and breastfeeding may have CV protective benefits as well. Social determinants of health play a significant role in these diseases; facts support that Black, Hispanic and Asian American women suffer from worse pregnancy outcomes than White American women. Join us while we discuss the recent American Heart Association (AHA) guideline update regarding the association of increased risk of CVD and metabolic disease with APOs and what can be done to reduce these risks. Episode resource links: Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women. Nisha I. Parikh, MD, MPH, Chair, Juan M. Gonzalez, MD, Cheryl A.M. Anderson, PhD, Suzanne E. Judd, PhD, Kathryn M. Rexrode, MD, Mark A. Hlatky, MD, Erica P. Gunderson, PhD, Jennifer J. Stuart, ScD, Dhananjay Vaidya, PhD, Vice Chair, On behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. https://www.ahajournals.org/doi/abs/10.1161/CIR.000000000000096 Schwartz, EB. (reviewing Parikh NI et al. Circulation 2021 Mar 29). Preventing Heart Disease in Women: New Guidance from the American Heart Association. NEJM: Journal Watch, April 12, 2021. https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart?ijkey=3l3eCvQLl Clinical Statements and Guidelines. AHA/ACOG Presidential Advisory. Volume 137, Issue 24, 12 June 2018, Pages e843-e852. https://doi.org/10.1161/CIR.0000000000000582 https://www.jwatch.org/na53433/2021/04/12/preventing-heart-disease-women-new-guidance-american-heart Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato

Continuous Glucose Monitoring—What’s All the Hype? - Frankly Speaking Ep 236
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-236 Overview: Continuous glucose monitoring (CGM) for patients with diabetes has been available for several years now, but its utility in managing diabetes care is unclear. Join us to discuss the results of a systematic review examining the benefits of CGM for patients with both type 1 and type 2 diabetes mellitus. Episode resource links: Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146-1156 Implementing Continuous Glucose Monitoring in Clinical Practice. www.aafp.org/fpm March/April 2021 Longo R, Sperling S. Personal versus professional continuous glucose monitoring: when to use which on whom. Diabetes Spectr. 2019;32(3):183-193. Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato

A Case of Severe Asthma: How Eosinophils Can Impact Asthma Evaluation and Treatment in Primary Care
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/severe-asthma-how-eosinophils-impact-evaluation-treatment Overview: Did you know that approximately two-thirds of adults with severe asthma are eosinophilic? The presence of eosinophilia can have implications for asthma management as well. Join Dr. Nicola Hanania, pulmonologist and asthma expert, as he reviews the case of a patient with severe asthma and discusses how primary care clinicians can identify eosinophilia, using common biomarkers, and improve outcomes in patients with eosinophilic asthma. Guest: Nicola Hanania, MD, MS, FACP, FCCP, FRCPC

Nasal Steroids for Perennial Allergic Rhinitis: Is PRN Use Enough? - Frankly Speaking Ep 235
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-235 Overview: Perennial allergic rhinitis affects both children and adults, and management includes both allergy avoidance as well as medication management. Intranasal steroids are the mainstay of treatment and have traditionally required consistent use, but new data are emerging. Find out the results of a new study evaluating PRN use as an alternative approach. Episode resource links: Thongngarm T, Wongsa C, Phinyo P, Assanasen P, Tantilipikorn P, Sompornrattanaphan M. As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1365-1373 Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato

Shorter Antibiotic Duration for Outpatient Infections - Frankly Speaking Ep 234
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-234 Overview: Many providers overtreat outpatient infections for fear of not treating until resolution or causing a complication, but this can lead to antibiotic resistance and adverse events. Join us to discuss the new ACP guidelines on antibiotic use in the outpatient setting and the pediatric treatment recommendations. Walk away with a clear understanding of the guidelines for optimal duration of antibiotic treatment for individuals with an outpatient infection. Episode resource links: ACP: Ann Intern Med. doi:10.7326/M20-7355; https://www.acpjournals.org/doi/pdf/10.7326/M20-7355 Low risk for PCN allergy: Am J Respir Crit Care Med 2020 Feb 21; [e-pub]. (https://doi.org/10.1164/rccm.202001-0089LE); Mayo Clinic Proceedings 2018, 93 (1): 101-107 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato

Taking the Distress out of Diabetes—Mindfulness and Acceptance Therapies May Help - Frankly Speaking Ep 233
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-233 Overview: T2DM is an epidemic, and its impact on quantity of life is well documented. In most cases, treatment involves significant lifestyle changes in combination with medication. Distress about the T2DM diagnosis and necessary behavioral changes occurs in about one-third of people, and this distress is associated with poor glycemic management. Join us as we discuss a recent meta-analysis on mindfulness and learn how cognitive therapies may be effective in reducing distress and HbA1c. Episode resource links: Ngan, H.Y., Chong, Y.Y. and Chien, W.T. (2021), Effects of mindfulness‐ and acceptance‐based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: Systematic review and meta‐analysis. Diabet Med, 38: e14525. https://doi.org/10.1111/dme.14525; https://onlinelibrary-wiley-com.umassmed.idm.oclc.org/doi/epdf/10.1111/dme.14525 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato

Community-Acquired Pneumonia: How Long Do We Need to Treat? - Frankly Speaking Ep 232
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-232 Overview: For patients with community-acquired pneumonia (CAP), wide variation in the duration of treatment exists. Longer duration of treatment may increase the risk of adverse effects and lead to antibiotic resistance. However, shorter duration of treatment may result in treatment failure. See what new evidence shows may be the best antibiotics treatment duration in most patients with CAP. Episode resource links: Dinh A et al. Pneumonia Short Treatment (PTC) Study Group. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet. 2021 Mar 27;397(10280):1195-1203 Metlay JP et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato

Pain in EVERYONE’s Neck - Frankly Speaking Ep 231
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-231 Overview: Who couldn’t use a refresher on how to diagnose and treat neck pain in the primary care setting? Review the techniques for assessing neck pain, determining its cause, and providing relief. Immediately apply what you learn to start helping patients with neck pain feel better. Episode resource links: Am Fam Physician 2016 May 1;93(9):746-54. Sub occipital Release: J Electromyogr Kinesiol 2016 Oct;30:31-7. doi: 10.1016/j.jelekin.2016.05.007 Self Myofascial Release: Spine 2020 Nov 1;45(21):E1367-E1375 Guest: Robert A. Baldor MD, FAAFP/Frank Music Credit: Richard Onorato

Perioperative Management for Patients Taking DOACs - Frankly Speaking Ep 230
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-230 Overview: Join us to discuss the results of the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) cohort study, aimed at understanding the safety of using a simplified perioperative management approach for patients with atrial fibrillation taking DOACs. After this episode, you’ll be able to make sense of the controversy over current guidelines around surgical care in this patient population. More importantly, you’ll walk away with practical knowledge to help these patients minimize their risk of adverse events. Episode resource links: Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med.2019; 179(11 ): 1469-14 78. doi: 10.1001 /jamainternmed.2019.2431 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato

Let’s Stop HIV Together & Pri-Med Part 2: 40 Year Recognition of HIV – Strategies for Ending the HIV Epidemic
Credits: 0.50 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/stop-hiv-together-2 Overview: The Ending the HIV Epidemic (EHE) initiative aims to reduce new HIV infections in the U.S. by 90% by 2030. This aim will be achieved by equitably and collaboratively delivering care and focusing resources on communities most affected by HIV, including those in Southern and rural areas. Join Dr. Charles Vega, Health Sciences Clinical Professor at UC Irvine Department of Family Medicine, and Dr. Leandro Mena, Chair and Professor of the Department of Population Health Science at University of Mississippi, and Director of the Center for HIV/AIDS Research, as they discuss how to provide culturally competent and collaborative care using the four EHE strategies: diagnose, treat, prevent, and respond. Guest: Leandro Mena, MD, MPH

Let’s Stop HIV Together & Pri-Med Part 1: 40 Year Recognition of HIV – Addressing Health Equity and Overcoming Barriers in Primary Care
Credits: 0.50 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/stop-hiv-together-1 Overview: HIV remains a persistent health problem for the United States and countries around the world. June marks 40 years since the first report of AIDS in CDC’s MMWR. Great progress has happened in the last 40 years in preventing and treating HIV. Yet there is still much to do. Join Dr. Charles Vega, Health Sciences Clinical Professor at UC Irvine Department of Family Medicine, and Dr. Oni Blackstock, primary care and HIV physician, researcher, and founder and executive director of Health Justice, racial and health equity consulting practice as they discuss how health and social inequities continue to affect the HIV epidemic. They will talk about the role primary care providers can play in ending the HIV epidemic. Guest: Oni Blackstock, MD, MHS